Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cloud buyout candidate, Could be a good one!
Bottom line is the final decision will most likely define the overall fate of the company as a whole. They are over 200million in the hole to date and with no means of adequate income it will be hard for them to find new investors and a buyout prospect is slim to none! Sad day for the kiddos! IMO
Yes, it was expected by realistic expectations!
WOW!!! They are not proposing a cure here people just an delay to the inevitable. IF it gets approved and that's a huge IF it might see $40 and that is a LOOOOOOOONG shot! IMO GLTA!
This POS is a sinking ship! Only a matter of time before this is trading back in the $4 range. Angie is more corrupt than Martha freaking Stewart! IMO
Gappppper! Weeeeeee Hope you sold some puts here too!
If the drug is not approved I am speculating that the price will plummet to around the $5-10 range maybe even worse and if it is approved double up. I don't care to openly speculate which way I think it's going to go but they are expecting about 1000 people at this Adcom. The 3rd scenario would be a neutral decision in which they would probably ask for more trials and give SRPT more time to prove the drug.
The FDA Advisory Committee (ADCOM) won't comment ahead of time. It is usually Pharma analysts that have something to say when pharma releases the meeting outline before Adcom. Pharma plays are really emotional and they can go either way really fast. The previous Adcom was canceled due to a lousy snow storm and it gapped down 20 bucks!
They usually release the FDA meeting outline 2-3 days before the panel meets. I have sold May calls and puts to take full advantage of the extrinsic value. I will also be buying some calls and puts prob mid week to hedge against any large gaps. It will also most likely be halted the day of adcom.
I saw it, looked toppy mid week, sold my calls bought some puts. plus I still have some way OTM calls and puts I sold short that will be expiring worthless =)
bankers say $VRX officials actively discussing sale of Bausch and Lomb unit we discuss bull case for stock NOW @FoxBusiness
Was thinking the same, looks toppy.
Do you have a link?
Riiiiiiiiiiiiiiiight! LOL
looook out beloooooow!
The commerce department is expected to issue its final rulings on China and Japan investigations on May 17 followed by final determinations on other five investigations on July 13. The USITC is also expected to make its final injury ruling on China and Japan in June and on five other countries in August.
Sure is! EOM
ADOC April 12th
rainbows and unicorns were unveiled by the FDA today! Weeeee to da moon!
it's called sarcasm lol!
If the most recents CLDX and VRX had been halted before there news maybe they wouldn't be in the toilet and investors would actually come back. I think it's out of respect of there investors either way.
IMO not a good sign! I have never seen a stock get halted for fears of panic buying!
Hey HC! I got this turd straddle and strangled fifteen ways til next week, no way to lose on this turd! Lol
These contracts decay faster than a snowman in July! :)
Gonna fall flat on it's face =()
Careful here fellas the last time this one missed the fda due to a measly snowstorm it gapped down 50%!
From Valeant's website...
Message to Valeant Employees from Mike Pearson
Share this on:
Twitter
|
Facebook
March 16, 2016
Dear Colleagues:
As you are probably aware, yesterday we announced fourth-quarter preliminary unaudited financial results on a call with investors and analysts. Clearly, there was an extreme market reaction to our financial update and our stock price realized a dramatic fall. I know that has caused many of you to worry about the health and future of this company. I want to assure you that our business is strong and I believe we are headed in the right direction.
First, I’d like to address an area that some have expressed concern over: whether the company is on the verge of bankruptcy. I can assure you we are not. The fears you might have read about in the press are tied to the delay in filing our 10-K financial report, which has deadlines that can trigger default of certain loans and bonds. This is a matter we are taking very seriously. We are working to extend the deadlines in our loan agreements, and I am confident we will be able to do so.
On the business side, all of the controversy over the past several months has clearly had an impact. The transition from Philidor hurt our results in the fourth quarter, and we are seeing other challenges in some of our businesses.
Our overall business continues to grow, but given the continued external pressure from managed care, the pricing environment and a slower-than-expected start to 2016, we are forecasting lower growth for some of our businesses, including U.S. dermatology – where we have transitioned from Philidor to Walgreens, gastrointestinal and women’s health, as well as certain geographic regions, such as Western Europe.
We continue to be encouraged by the strong growth in contact lenses, oral health, oncology, generics and some of our emerging markets. These are all great businesses that are delivering on their plans and generating cash. We’re also confident about our ability to get some of our businesses that have gotten off to slow starts in 2016 back on track, including prescription ophthalmology, Solta and Obagi.
Additionally, the Walgreens program is off to a terrific start. Within two months of launch, approximately 30 percent of our dermatology scripts are flowing through Walgreens – approximately twice the volume from when we started. More importantly, well over 90% of the physicians who were using Philidor are now using Walgreens and many new doctors are using the channel as well. We continue to fine tune the program and the next phase of the program, brand-for-generics, is on track for launch this summer.
Restoring the public’s confidence will take time and I want to apologize directly to each of you for the distractions this intense scrutiny is causing you. I know you want to wake up happy to come to work every day, and over the past few months, that has been difficult. Please know that I am working as hard as I can to turn things around, and I believe we will. I truly believe we have the right fundamentals in place: a great set of products and brands; loyal physicians, patients and customers, and most of all, you – our employees worldwide who are doing everything you can to provide important medicines to our patients and the doctors who depend on them. It is because of you that I’m confident we can get past this period of uncertainty, restore our reputation and make you all feel proud once again to work at Valeant.
Thank you for all of your hard work. If there is anything you think we can be doing better, please don’t hesitate to let me know.
Regards,
Mike
Okay, I will sell! lol
Boooooooom!
Calls too, it's crazy!
Just what this POS needs, more chiefs in the village! lol
Breeeeeeeath!
Beeeeaast mode for sure HC!
Lateral movers are the best! Weeeeeeeee!
These numbers have not been verified by any third party and represent the Company’s estimates as of the date indicated. The Company assumes no obligation to update them.
So in other words they are full of SHIT! IMO
Talk about market over reaction!
ALL of the following is my opinion! It's hard to say what the real numbers of visitors are. I honestly don't know what consumer would be dumb enough to pay them for their services when there are so many free sites out there. Not only that but if you are dissatisfied with someone you find on their site they WON'T let you leave bad feedback for them without making you jump through hoops first!
Home advisor is everywhere even though you may not realize it. For example., I recently googled heater install and the town of the rental I was looking for and a phone number popped up with a company so I called it. A operator answered and took my name and number and in 30mins someone called me back. Well it turns out it was Home Advisors service that the heating company payed to get them business. Which worked great by the way!
Angi has reinvented themselves so many times over the last 10 years I don't even know if they know what they are, the least of all profitable! And really late to game!
Jim Cramer was pumping the steel sector on his show yesterday! Weeeeeeeee
When corporations do it it's called "price fixing", when governments do it it's called "capping"! LOL
3-9-2016 The DOC, on Tuesday, imposed a whopping duty rate of 265.79% on imports of cold-rolled steel from China. Chinese companies did not respond to the DOC's request for information and thus, got punished with big tariffs. This will badly hit Chinese exporters such as Angang Group Hong Kong Co., Ltd., Benxi Iron and Steel (Group) Special Steel Co., Ltd. and Qian'an Golden Point Trading Co., Ltd. Brazil and Japan exporters received duties of 38.93% and 71.35%, respectively.
The DOC will now instruct U.S. Customs and Border Protection to start requiring cash deposits based on the duty rates for cold-rolled steel imports from these seven countries. In Dec 2015, the commerce department imposed countervailing duties on imports of cold-rolled steel from Brazil, China, India and Russia including a massive duty rate of 227.29% on China.
The biggest U.S. steel producers - U.S. Steel $X, AK Steel $AKS, Nucor $NUE, Steel Dynamics $STLD and ArcelorMittal USA, a part of ArcelorMittal $MT - filed anti-dumping petitions in Jul 2015 with the U.S. International Trade Commission ("USITC") and the DOC against eight countries (Brazil, China, India, Japan, the Netherlands, Russia, South Korea and the UK) alleged for illegally dumping cold-rolled steel that is used to make automotive products and appliances, among others.
Read more: http://www.nasdaq.com/article/steel-stocks-take-flight-as-us-slaps-antidumping-duties-cm588120#ixzz425QQHTyq